Literature DB >> 16239542

Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity.

Jason B Harris1, Ashraful I Khan, Regina C LaRocque, David J Dorer, Fahima Chowdhury, Abu S G Faruque, David A Sack, Edward T Ryan, Firdausi Qadri, Stephen B Calderwood.   

Abstract

Individuals with blood group O are more susceptible than other individuals to severe cholera, although the mechanism underlying this association is unknown. To assess the respective roles of both intrinsic host factors and adaptive immune responses that might influence susceptibility to infection with Vibrio cholerae, we prospectively followed a cohort of household contacts of patients with cholera in Bangladesh. In this study, we made the novel observation that persons with blood group O were less likely than those with other blood groups to become infected with V. cholerae O1 (odds ratio [OR], 0.67; 95% confidence interval [CI], 0.53 to 0.85; P = 0.008). Consistent with prior studies, however, household contacts with blood group O were more likely to develop severe illness if infected with V. cholerae O1 (OR, 2.3; 95% CI, 0.98 to 5.59; P = 0.05). While blood group O protected significantly against infection with V. cholerae O1, there was no evidence of protection against V. cholerae O139. A multivariate analysis demonstrated that the association between blood group O and protection from infection with V. cholerae O1 was independent of age, gender, and baseline anti-cholera toxin and vibriocidal antibody titers. Based on this epidemiologic evidence, we propose a hypothesis for understanding the association between blood group O and the risk of infection with V. cholerae O1 and O139 as well as the risk of developing severe symptoms once infected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239542      PMCID: PMC1273892          DOI: 10.1128/IAI.73.11.7422-7427.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.

Authors:  E E Richie; N H Punjabi; Y Y Sidharta; K K Peetosutan; M M Sukandar; S S Wasserman; M M Lesmana; F F Wangsasaputra; S S Pandam; M M Levine; P P O'Hanley; S J Cryz; C H Simanjuntak
Journal:  Vaccine       Date:  2000-05-08       Impact factor: 3.641

2.  ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy.

Authors:  J D Clemens; D A Sack; J R Harris; J Chakraborty; M R Khan; S Huda; F Ahmed; J Gomes; M R Rao; A M Svennerholm
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.

Authors:  R I Glass; A M Svennerholm; M R Khan; S Huda; M I Huq; J Holmgren
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

5.  Possible role of blood-group secretory substances in the aetiology of cholera.

Authors:  A Chaudhuri; C R DasAdhikary
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

6.  Inhibition of cholera toxin binding to membrane receptors by pig gastric mucin-derived glycopeptides: differential effect depending on the ABO blood group antigenic determinants.

Authors:  C G Monferran; G A Roth; F A Cumar
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

7.  Predisposition for cholera of individuals with O blood group. Possible evolutionary significance.

Authors:  R I Glass; J Holmgren; C E Haley; M R Khan; A M Svennerholm; B J Stoll; K M Belayet Hossain; R E Black; M Yunus; D Barua
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

8.  Evolutionary origin of pathogenic determinants in enterotoxigenic Escherichia coli and Vibrio cholerae O1.

Authors:  T Yamamoto; T Gojobori; T Yokota
Journal:  J Bacteriol       Date:  1987-03       Impact factor: 3.490

9.  Genetic susceptibility to cholera.

Authors:  M M Levine; D R Nalin; M B Rennels; R B Hornick; S Sotman; G Van Blerk; T P Hughes; S O'Donnell; D Barua
Journal:  Ann Hum Biol       Date:  1979 Jul-Aug       Impact factor: 1.533

10.  Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures.

Authors:  M Rahman; D A Sack; S Mahmood; A Hossain
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

View more
  78 in total

1.  Cholera: lessons from haiti and beyond.

Authors:  Ana A Weil; Louise C Ivers; Jason B Harris
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

3.  A large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher response.

Authors:  T Ramamurthy; Diane Wagener; Goutam Chowdhury; Partha P Majumder
Journal:  Clin Vaccine Immunol       Date:  2010-06-16

4.  Fucosylation and protein glycosylation create functional receptors for cholera toxin.

Authors:  Amberlyn M Wands; Akiko Fujita; Janet E McCombs; Jakob Cervin; Benjamin Dedic; Andrea C Rodriguez; Nicole Nischan; Michelle R Bond; Marcel Mettlen; David C Trudgian; Andrew Lemoff; Marianne Quiding-Järbrink; Bengt Gustavsson; Catharina Steentoft; Henrik Clausen; Hamid Mirzaei; Susann Teneberg; Ulf Yrlid; Jennifer J Kohler
Journal:  Elife       Date:  2015-10-29       Impact factor: 8.140

Review 5.  Prevention and self-treatment of traveler's diarrhea.

Authors:  David J Diemert
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 6.  Genetics of susceptibility to infection with enteric pathogens.

Authors:  Jose Flores; Pablo C Okhuysen
Journal:  Curr Opin Infect Dis       Date:  2009-10       Impact factor: 4.915

7.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

8.  Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera.

Authors:  F Matthew Kuhlmann; Srikanth Santhanam; Pardeep Kumar; Qingwei Luo; Matthew A Ciorba; James M Fleckenstein
Journal:  Am J Trop Med Hyg       Date:  2016-05-09       Impact factor: 2.345

9.  Genomic correlates of variability in immune response to an oral cholera vaccine.

Authors:  Partha P Majumder; Neeta Sarkar-Roy; Herman Staats; T Ramamurthy; Sujit Maiti; Goutam Chowdhury; Carol C Whisnant; K Narayanasamy; Diane K Wagener
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

10.  Cholera in pregnancy: Clinical and immunological aspects.

Authors:  Ashraful I Khan; Fahima Chowdhury; Daniel T Leung; Regina C Larocque; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Int J Infect Dis       Date:  2015-08-14       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.